Pure Global

"Caudix" Pross Pronickel Titanium Bracket System - Taiwan Registration 9dcec3b701653f47d454910ad7fc622c

Access comprehensive regulatory information for "Caudix" Pross Pronickel Titanium Bracket System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 9dcec3b701653f47d454910ad7fc622c and manufactured by Cordis US Corp.;; Cardinal Health Mexico 244 S. de R.L. de C.V.. The authorized representative in Taiwan is EMERGO TAIWAN LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
9dcec3b701653f47d454910ad7fc622c
Registration Details
Taiwan FDA Registration: 9dcec3b701653f47d454910ad7fc622c
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Caudix" Pross Pronickel Titanium Bracket System
TW: โ€œ่€ƒ่ฟชๆ–ฏโ€ๆ™ฎ่ณฝๆ–ฏๆ™ฎ็พ…้Žณ้ˆฆๆ”ฏๆžถ็ณป็ตฑ
Risk Class 3

Registration Details

9dcec3b701653f47d454910ad7fc622c

DHA00602143400

Company Information

Product Details

The Cordis Precise PRO RX Nitinol Stent System is used in conjunction with the Cordis ANGIOGUARD RX Embolic Capture Guide System and is suitable for the treatment of patients who must undergo carotid vascular repair and carotid endarterectomy may cause adverse reactions, and must meet the following conditions: 1. Have neurological symptoms and are diagnosed with total carotid artery or internal carotid artery stenosis by ultrasound or angiography โ‰ฅ 50% 80% of patients, or no neurological symptoms, but diagnosed with total carotid artery or internal carotid artery stenosis by ultrasound or angiographyโ‰ฅ and 2. The diameter of the blood vessel of the patient's target lesion must be 4-9mm. THE TARGET LESION MUST BE BETWEEN 3 MM AND 7.5 MM FROM THE END OF THE VESSEL TO INSERT THE ANGIOGUARD RX EMBOLIC CAPTURE GUIDE.

E Cardiovascular Medicine Science

E.0001 Cardiovascular stents

import

Dates and Status

Oct 12, 2022

Sep 07, 2025